Studies of non-small cell lung cancer patients and breast cancer patients found no substantial alterations in vWF:Ag levels compared to reference controls [22,23], and a clinical trial of human patients with colorectal cancer found significantly elevated levels of plasma vWF but was unable to clearly define the related role in cancer progression [24]. The gene discussed is RENBP; the disease is breast cancer.